Study to Evaluate the Efficacy of Poppi Apple Cider Vinegar Prebiotic Soda to Improve Gut Health In Participants - Trial NCT05418439
Access comprehensive clinical trial information for NCT05418439 through Pure Global AI's free database. This phase not specified trial is sponsored by Drink Poppi and is currently Completed. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 38 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Drink Poppi
Timeline & Enrollment
N/A
Apr 01, 2022
May 01, 2022
Primary Outcome
Change in IBS symptoms [Time Frame: Baseline to 4 weeks),Change in bowel movements [Time Frame: Baseline to 4 weeks),Change in skin health [Time Frame: Baseline to 4 weeks)
Summary
This exploratory observational trial provides the opportunity to gather information on the
 effect of daily consumption of Poppi Apple Cider Vinegar Prebiotic Soda on gut health and
 digestion.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05418439
Non-Device Trial